Reimaginamos la medicina para mejorar y prolongar la vida de las personas | Nuestras normas de la comunidad: https://t.co/HiQC66XFca" title="" class="btn" data-container="body" data-html="true" data-id="35728" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Novartis España"> 20,757 8,984 6,588 200 29,685 22,868 48,998 301,870 35,321 347 344 4,480 10,439 883 1,016 1,872 4,048,258
Sectors
Location
Fabrikstrasse 2, 4056 Basel, Switzerland
Basel
Switzerland
Engaged entities
1851Added in Motherbase
29 Apr 2019, 3:39 p.m.Reimagining medicine, together
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Find out more at https://www.novartis.com
See our community guidelines: https://go.novartis.social/3Nboxki
Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy
Novartis
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
![]() | INFYNITY BIOMARKERS SAS Biotechnology Research, biotech, deeptech | Other 16 Apr 2025 | | |
![]() | TreeFrog Therapeutics Biotechnology Research, biotech, deeptech | Other 12 Apr 2025 | | |
![]() | Cancéropôle Est biotech, deeptech | Other 15 Apr 2025 | | |
![]() | 64x Bio Biotechnology Research, biotech, deeptech | Other 28 Feb 2025 | | |
![]() | Ancora.ai Hospitals and Health Care, healthtech, deeptech | Other 6 Apr 2025 | | |
![]() | TAg35 Civic and Social Organizations, civictech | Other 11 Apr 2025 | | |
![]() | French National Rare Disease Registry healthtech | Other 28 Feb 2025 | | |
![]() | iOnctura Biotechnology Research, biotech, deeptech | Other 23 Mar 2025 | | |
![]() | Parloa Software Development, it services | Other 2 Apr 2025 | | |
![]() | GenSearch Staffing and Recruiting, hrtech, healthtech, biotech, deeptech | Other 3 Apr 2025 | |